Adaptive Hybrid Surgery* – Technology



When it comes to follow-up radiosurgery for benign skull base tumors, most neurosurgeons don’t have detailed knowledge about fractionation schemes, toxicity constraints, etc. Also radiosurgery plans typically take experienced physicists hours to generate, making pre-surgical evaluation impractical and intraoperative assessments impossible. In the lack of such objective measure it’s very hard to quantify the extent of subtotal resection needed, to leave a good radiosurgical target. Given these challenges, how can radiosurgery guide surgery? How can software help neurosurgeons to make on-the-fly decisions whether a specific residual tumor at any time during surgery is a good radiosurgical target and would therefore result in a good overall treatment? Watch the video to learn about how new Brainlab technology* addresses such demands and how additional information may provide guidance to neurosurgeons in difficult skull base interventions. To learn more visit us at CNS booth #542. *FDA clearance pending